Publishing Industry Mergers: They May Be Bad For Science

Scholarly and academic publishing is now in a state of unprecedented turmoil because of mergers and takeovers. Harper & Row is now linked with Collins (UK); D. Reidel in Europe has joined with Kluwer British publisher Longman has absorbed Addison-Wesley. Harcourt Brace Jovanovich fought off a raid by Robert Maxwell, but went into debt in the process and was forced to lay off staff. Such events are relatively new in the publishing world. Until World War II, science publishing was very much a

Written bySimon Mitton
| 4 min read

Register for free to listen to this article
Listen with Speechify
0:00
4:00
Share

Scholarly and academic publishing is now in a state of unprecedented turmoil because of mergers and takeovers. Harper & Row is now linked with Collins (UK); D. Reidel in Europe has joined with Kluwer British publisher Longman has absorbed Addison-Wesley. Harcourt Brace Jovanovich fought off a raid by Robert Maxwell, but went into debt in the process and was forced to lay off staff.

Such events are relatively new in the publishing world. Until World War II, science publishing was very much a national affair. Books moved from one market to another through agency arrangements. The very best books got translated into other languages. Then, improved communications encouraged pubushers to set up their own branches overseas and expand markets in specific areas. Among United States publishers, for example, McGraw-Hill and Wiley became major international purveyors of books on science, technology, and medicine, while in Europe, ier flourished in the Netherlands ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies